NINLARO 4mg TK (Ixazomib Capsule) 4MG

NINLARO 4mg TK (Ixazomib) is an oral proteasome inhibitor capsule used in cancer therapy. This 4MG strength supports targeted treatment protocols. Discover how ixazomib works and its role in managing certain conditions.

Strength

4MG

Manufacturer / TM Owner

Takeda Pharma AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ixazomib is prescribed for patients requiring proteasome inhibition as part of their treatment plan. It is used in combination with other medications to address specific medical needs. What is ixazomib used for in cancer care? This medication is indicated for certain types of malignancies where targeted therapy is beneficial.

Side Effects

Common effects may include gastrointestinal discomfort or fatigue during therapy. Some patients report changes in appetite or mild skin reactions. These responses vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

Store capsules at room temperature away from moisture and heat. Keep out of reach of children and pets. Always follow your doctor’s instructions for handling and disposal. Report any unusual symptoms promptly to your healthcare team.

Avoid Interactions

Certain medications may affect how ixazomib works, including CYP3A inhibitors or inducers. Avoid grapefruit products unless approved by your doctor. Discuss all current prescriptions and supplements with your healthcare provider before starting ixazomib.

Frequently Asked Questions

Ixazomib is used in cancer therapy as part of a treatment regimen for certain malignancies.

Store at room temperature, away from moisture and heat, and keep out of reach of children.

Some medications may interact; consult your healthcare provider before combining therapies.

Gastrointestinal discomfort, fatigue, and changes in appetite are commonly reported.

Ixazomib is available as a branded medication; generic versions may vary by region.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.